Product How it works Pricing Blog FAQ About Contact
Prothena Corporation Public

Prothena Corporation Public (NASDAQ: PRTA) revenue

Prothena Corporation Public reported revenue of $9.7m for fiscal 2025, 92.8% less than in fiscal 2024 ($135.2m). Since fiscal 2016 its revenue has grown by 817.9%, an average growth of 27.9% a year.

Prothena Corporation Public's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2018, −96.5%.

Revenue, in millions of US dollars1.1201627.520171.020180.820190.92020200.6202153.9202291.42023135.220249.72025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$9.7m−92.8%−$214.6m−2,216.4%
2024$135.2m+47.9%−$154.6m−114.4%
2023$91.4m+69.5%−$191.0m−209.1%
2022$53.9m−73.1%−$131.6m−244.1%
2021$200.6m+23,414.3%$72.0m35.9%
2020$0.9m+4.8%−$112.7m−13,216.2%
2019$0.8m−14.8%−$85.7m−10,527.9%
2018$1.0m−96.5%−$158.9m−16,634.0%
2017$27.5m+2,508.4%−$155.3m−564.2%
2016$1.1m—−$159.5m−15,121.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Prothena Corporation Public revenue compared with its sector

By revenue for its latest fiscal year, Prothena Corporation Public ranks 371st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Prothena Corporation Public, −92.8%.

RankCompanyRevenueRevenue growth
369thTaysha Gene Therapies$9.8m17.3%
370thPrecigen$9.7m146.7%
371stProthena Corporation Public$9.7m−92.8%
372ndBioage Labs$9.0m—
373rdRoivant Sciences$8.3m−71.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Prothena Corporation Public

How much revenue did Prothena Corporation Public make in fiscal 2025?
Prothena Corporation Public reported revenue of $9.7m for fiscal 2025, compared with $135.2m in fiscal 2024.
How much has the revenue of Prothena Corporation Public grown?
Between fiscal 2016 and fiscal 2025 it went from $1.1m to $9.7m: 817.9% more, an average growth of 27.9% a year.
What was the best year for revenue at Prothena Corporation Public?
Of its last 10 fiscal years, fiscal 2021, with $200.6m.
Where does Prothena Corporation Public rank in its sector by revenue?
It ranks 371st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Prothena Corporation Public come from?
From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Prothena Corporation Public: the Prothena Corporation Public page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.